The Anticancer Activity and HSA Binding Properties of the Structurally Related Platinum (II) Complexes

The development of resistance and unwanted harmful interaction with other biomolecules instead of DNA are the major drawbacks for application of platinum (Pt) complexes in cancer chemotherapy. To conquer these problems, much works have been done so far to discover innovative Pt complexes. The objective of the current study was to evaluate the anti cancer activities of a series of four and five-coordinated Pt(II) complexes, having deprotonated 2-phenyl pyridine (abbreviated as C^N), biphosphine moieties, i.e., dppm?=?bis(diphenylphosphino) methane (Ph₂PCH₂PPh₂) and dppa?=?bis(diphenylphosphino)amine (Ph₂PNHPPh₂), as the non-leaving carrier groups. The growth inhibitory effect of the Pt complexes [Pt(C^N)(dppm)]PF₆: C ₁ , [Pt(C^N)(dppa)]PF₆: C ₂ , and [Pt(C^N)I(dppa)]: C ₃ , toward the cancer cell lines was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. In addition, the florescence quenching experiments of the interaction between human serum albumin (HSA) and the Pt complexes were performed in order to obtain the binding parameters and to evaluate the denaturing properties of these complexes upon binding to the general carrier protein of blood stream. The structure?Cactivity relationship studies reveal that four-coordinated Pt complexes C ₁ and C ₂ with both significant hydrophobic and charge characteristics, not only exhibit strong antiproliferation activity toward the cancer cell lines, but also they display lower denaturing effect against carrier protein HSA. On the other hand, five-coordinated C ₃ complex with the unusual intermolecular NH??Pt hydrogen binding and the intrinsic ability for oligomerization, exhibits poor anticancer activity and strong denaturing property. The current study reveals that the balance between charge and hydrophobicity of the Pt complexes, also their hydrogen binding abilities and coordination mode are important for their anticancer activities. Moreover, this study may suggest C ₁ and C ₂ as the potential template structures for synthesis of new generation of four-coordinated Pt complexes with strong anticancer activities and weak denaturing effects against proteins.     

Mononuclear Cu(II), Zn(II), and Co(II) Complexes with 2-Furoate Anions and 2,2'-Bpy: Synthesis,Structure, and Biological Activity

Russian Journal of Coordination Chemistry - The mononuclear complexes [M(Fur)2(Bpy)(H2O)] (M = Cu (I), Zn (II)) were prepared by the reactions of copper(II) and zinc(II) acetates with 2-furoic acid...     

DNA as a Target for Anticancer Phen-Imidazole Pd(II) Complexes

Imidazole ring is a known structure in many natural or synthetic drug molecules and its metal complexes can interact with DNA and do the cleavage. Hence, to study the influence of the structure and size of the ligand on biological behavior of metal complexes, two water-soluble Pd(II) complexes of phen and FIP ligands (where phen is 1,10-phenanthroline and FIP is 2-(Furan-2-yl)-1H–Imidazo[4,5-f][1, 10]phenanthroline) with the formula of [Pd(phen)(FIP)](NO₃)₂ and [Pd(FIP)₂]Cl₂, that were activated against chronic myelogenous leukemia cell line, K562, were selected. Also, the interaction of these anticancer Pd(II) complexes with highly polymerized calf thymus DNA was extensively studied by means of electronic absorption, fluorescence, and circular dichroism in Tris-buffer. The results showed that the binding was positive cooperation and [Pd(phen)(FIP)](NO₃)₂ (K _f = 127 M^-1 G = 1.2) exhibited higher binding constant and number of binding sites than [Pd(FIP)₂]Cl₂ (K _f = 13 M^-1 G = 1.03) upon binding to DNA. The fluorescence data indicates that quenching effect for [Pd(phen)(FIP)](NO₃)₂ (K _SV = 58 mM^?1) was higher than [Pd(FIP)₂]Cl₂ (K _SV = 12 mM^?1). Also, [Pd(FIP)₂]Cl₂ interacts with ethidium bromide-DNA, as non-competitive inhibition, and can bind to DNA via groove binding and [Pd(phen)(FIP)](NO₃)₂ can intercalate in DNA. These results were confirmed by circular dichroism spectra. Docking data revealed that longer complexes have higher interaction energy and bind to DNA via groove binding.

Open image in new window

Graphical Abstract Two anticancer Pd(II) complexes of imidazole derivative have been synthesized and interacted with calf thymus DNA. Modes of binding have been studied by electronic absorption, fluorescence, and CD measurements. [Pd(FIP)₂]Cl₂ can bind to DNA via groove binding while intercalation mode of binding is observed for [Pd(phen)(FIP)](NO₃)₂.

     

Square Planar Platinum(II) Complexes with N,S-Donor Ligands: Synthesis,Characterisation, DNA Interaction and Cytotoxic Activity

The platinum(II) complexes with N,S-donor ligand have been synthesised and characterised by physiological techniques like elemental, electronic, Fourier transform infrared, hydrogen-1 nuclear magnetic resonance (¹H NMR) and liquid chromatography–mass spectrometry spectra. The synthesised complexes have been checked for their DNA binding ability by absorption titration and viscosity measurement, and the results show that the complexes binds to herring sperm DNA (HS DNA) via covalent mode of binding. The DNA cleavage activity of synthesised complexes has been carried out by gel electrophoresis experiment using supercoiled form of pUC19 DNA, showing the unwinding of the negatively charged supercoiled DNA. Brine shrimp (Artemia cysts) lethality bioassay technique has been applied for the determination of toxic property of synthesised complexes in terms of micromolars.     

类姜黄素-芳基钌配合物的合成、结构和光照激活抗癌活性

合成了3种含姜黄素衍生物（L¹~L³）和1,3,5-三氮杂-7-磷金刚烷（PTA）配体的芳基钌配合物[（η⁶-p-cymene）Ru（L）（PTA）]PF₆（1~3,L=L¹~L³）,通过X射线单晶衍射、核磁共振波谱、高分辨质谱、元素分析等方法表征了这些配合物的结构,并用MTT法研究了它们在λ>400 nm的光照辅助下对HepG2人肝癌细胞的增殖抑制活性。结果表明,这3个配合物均为半三明治型结构;光辅助下,配合物抗癌活性明显提高,其中配合物3对HepG2细胞的IC₅₀值从（60.3±1.1）μmol·L^-1降低至（45.0±6.1）μmol·L^-1。说明光照可以有效提高此类配合物的抗肿瘤活性。     

Syntheses,Structures and Anticancer Activity of NNO‐Tridentate Schiff Base Copper(II) Complexes

A series of heteroleptic copper(II) complexes [Cu( ^R QYMP )(Py]] ( 1a ‐ 4d ) supported on NNO‐tridentate Schiff base ( ^R QYMP ‐H) and bipyridine (Py=bpy, a ; phen, b ; dpq, c ; dppz, d ) co‐ligands have been synthesized and characterized. X‐ray crystal structural studies of complexes 1b , 2c , 3d and 4a displays that these complexes are mononuclear with a distorted square pyramidal geometry around the copper center. Cytotoxicity results indicate that all of these complexes have much higher activity against HeLa, SCC15, BCC and Ca9‐22 cancer cell lines as compared to cisplatin. Further, copper complex bearing suitable bulky group Schiff base ligands with dppz co‐ligand could be considered in designing efficient metalbased anticancer agents.     

吩噻嗪-Corrole 镓(III)配合物的合成、荧光及其光断裂DNA性质

合成了吩噻嗪(PTZ)-corrole二元体1-3及其镓(III)配合物4-6.采用稳态吸收与稳态发射及时间分辨的瞬态光谱技术研究了这几种化合物的光物理特性.结合荧光量子产率和荧光寿命计算得到它们的辐射和无辐射速率常数.稳态吸收光谱表明:几种二元体中,corrole镓(III)单元表现出更强的Soret带和Q带.化合物1-3的荧光量子产率分别是0.156、0.134和0.139,辐射速率常数分别为4.02′107、3.47′107和2.89′107s-1.化合物4-6的荧光量子产率分别是0.502、0.443和0.494,辐射速率常数分别为20.90′107、16.78′107和21.11′107s-1.可见,化合物4-6的荧光量子产率和辐射速率常数均高于化合物1-3.然而,化合物4-6的荧光寿命分别是2.40、2.64和2.34ns,低于自由corrole1-3.琼脂糖凝胶电泳实验表明:在光照的条件下,这些吩噻嗪-corrole镓(III)二元体化合物能够把超螺旋DNA(formI)切割成缺刻型DNA(formII).     

Phen-铜(II)-氨基酸配合物的合成、表征及其SOD活性

合成了3个新的SOD模拟配合物：[Cu(Phen)(L-Gln)(H₂O)]Cl·2H₂O (1)、[Cu(Phen)(L-Ala)(H₂O)]Cl·4H₂O (2)、[Cu(Phen)(L-Thr)(H₂O)]Cl·2H₂O (3) [Phen(1，10-邻菲咯啉)、L-Gln(谷氨酰胺)、L-Ala(丙氨酸)、L-Thr(苏氨酸)]。用元素分析、摩尔电导、红外光谱、紫外-可见光谱对配合物进行了表征。用X-射线衍射对配合物[Cu(Phen)(L-Gln)(H₂O)]Cl·2H₂O的晶体结构进行了测定。用氯化硝基四氮唑蓝(NBT)光还原法对这3个配合物催化歧化超氧阴离子自由基(O₂^{- ·})的能力进行了测定。结果表明：这些配合物具有较高的SOD活性， 催化速率常数K_Q分别为1.58 × 10⁷ mol^-1·L·s^-1、5.65 × 10⁷ mol^-1·L·s^-1、0.83 × 10⁷ mol^-1·L·s^-1。     

Pd(II) and Pt(II) Complexes of 2-Phenyl- and 2-Benzyl-imidazoline: Synthesis,Structural Characterization,DNA Modification and in vitro Antileukaemic Activity

In this paper we describe the synthesis and chemical characterization of three new Pd(II)–imidazoline complexes: [PdCl₂ (C₆H₅–CH₂–C₃H₅N₂)₂] (2), [PdCl(SEt₂) (C₆H₄-C₃H₅N₂)] (5) and [Pd(C₆H₄-C₃H₅N₂) (μ-Br)]₂ (6). We have also analyzed the DNA modifications and in vitro antileukaemic activity of these compounds and of their previously reported analogs [Pd Cl₂ (C₆H₅–C₃H₅N₂)₂] (1), [Pd (C₆H₄–C₃H₅N₂) (μ-OAc)]₂ (3), [Pd (C₆H₄–C₃H₅N₂) (μ-Cl)]₂ (4) and [Pt(C₆H₄–C₃H₅N₂)(μ-Cl] (7). All these compounds modify the DNA secondary structure since they alter the melting temperature (T_m) of the DNA. Circular dichroism spectra indicated, moreover, that compounds 3, 5 and 6 induced higher modification on the double helix than compounds 1, 2 and 4. While compounds 1, 2 and 5 seem to induce slight changes in the electrophoretic mobility of the open and covalently closed circular forms of pUC8 DNA at high r_i (input molar ratio of Pd or Pt to nucleotides), compounds 3, 6 and 7 do not modify at any r_i the tertiary structure of the plasmid DNA. Antileukaemic tests suggest that compounds 1, 4 and 7 exhibit important cytotoxic activity since their IC₅₀ values against HL-60 human leukaemic cells were below 10 μg ml⁻¹. © 1997 John Wiley & Sons, Ltd.     

Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells

Hypoxia is the critical feature of the tumor microenvironment that is known to lead to resistance to many chemotherapeutic drugs. Six novel ruthenium(II) anthraquinone complexes were designed and synthesized; they exhibit similar or superior cytotoxicity compared to cisplatin in hypoxic HeLa, A549, and multidrug‐resistant (A549R) tumor cell lines. Their anticancer activities are related to their lipophilicity and cellular uptake; therefore, these physicochemical properties of the complexes can be changed by modifying the ligands to obtain better anticancer candidates. Complex 1 , the most potent member of the series, is highly active against hypoxic HeLa cancer cells (IC₅₀=0.53 μM ). This complex likely has 46‐fold better activity than cisplatin (IC₅₀=24.62 μM ) in HeLa cells. This complex tends to accumulate in the mitochondria and the nucleus of hypoxic HeLa cells. Further mechanistic studies show that complex 1 induced cell apoptosis during hypoxia through multiple pathways, including those of DNA damage, mitochondrial dysfunction, and the inhibition of DNA replication and HIF‐1α expression, making it an outstanding candidate for further in vivo studies.     

二胺桥联邻菲咯啉镧(Ⅲ)配合物的合成及抗癌活性研究

本文合成、表征了乙二胺、1,3-丙二胺和1,2-丙二胺桥联邻菲咯啉配体及其镧(Ⅲ)配合物,研究了配合物对人白血病HL60、人前列腺癌PC-3MIE8、人胃癌BGC-823、人乳腺癌MDA-MB-435、人肝癌Bel-7402、人宫颈癌Hela等6个瘤株的体外抗肿瘤活性及其与DNA的作用方式,结果表明该系列化合物对实验的6种瘤株均具有明显的生长抑制作用,具有广谱性。其作用机理可能是配合物以部分插入方式,同时伴随共价作用与静电作用与DNA发生作用,进而影响基因调控与表达,抑制肿瘤细胞的生长,最终导致癌细胞的凋亡。     

Palladium(II) Complexes with Catecholamines: Synthesis and In Vitro Cytotoxic Activity

Russian Journal of General Chemistry - The reactions of palladium(II) chloride with catecholamines (hydrochlorides of 3-methoxytyramine, normetanephrine, norepinephrine, and dopamine) and...     

Synthesis,Spectroscopy, and Anticancer Activity of Two New Nanoscale Au(III) N4 Schiff Base Complexes

Russian Journal of General Chemistry - Mononuclear Au(III) Schiff base complexes are synthesized by the reaction of 4-aminoantipyrine with hydrazine. The chemical structures of new Schiff bases and...     

Synthesis,Properties and Crystal Structures of Mononuclear Copper(II) Complexes with Bis(2-Pyridylmethyl)Amino Acids

Tetradentate Schiff-base carboxylate-containing ligands, bis(2-pyridylmethyl)amino-3-propionic acid (Hpmpa) and bis(2-pyridylmethyl)amino-4-butyric acid (Hpmba), react with CuCl₂ to give rise to the mononuclear complexes [Cu(Hpmpa)Cl]Cl · 2H₂O (1) and [Cu(Hpmba)Cl₂]· H₂O (2). These complexes have been characterized by X-ray crystallography, spectroscopic and cyclic voltammetry. Crystal structure of (1) shows that the copper(II) ion has a distorted square-pyramidal geometry with the three nitrogen atoms of the Hpmpa ligand and one chloride anion occupying the basal plane and an oxygen atom from the carboxylate group coordinating the axial position. In (2), the coordination environment around the copper(II) ion reveals a distorted square-pyramids with three nitrogen atoms of the Hpmba ligand and one chloride anion that comprise the basal plane, whereas the apical position is filled by the chloride anion. Cyclic voltammetry of the complexes gives two one-electron waves corresponding to Cu^II/Cu^III and Cu^III/Cu^I processes. The electronic spectra and redox potentials of the complexes are influenced significantly by the N-pendant carboxylate groups.     

Synthesis,Characterization, DNA Binding Properties,and Antioxidant Activity of Novel Copper(II) and Zinc(II) Complexes with Bis(pyrrol‐2‐yl‐methylamine) Ligands

Three novel ligands H₄Lⁿ (n = 1–3) and their copper(II) and zinc(II) complexes were prepared and characterized on the basis of elemental analyses, molar conductivity, ¹H NMR, UV/Vis, and IR spectroscopy as well as mass spectrometry. DNA binding properties of the ligands and their complexes were investigated by absorption spectroscopy, ethidium bromide displacement experiments, and viscosity measurements. The experimental results indicate that the new ligands and their complexes can bind to DNA and the binding affinities of the complexes are higher than those of the ligands. In addition, the antioxidant activity of the ligands and complexes was determined by superoxide and hydroxyl radical scavenging methods in vitro, indicating that the complexes exhibit more effective antioxidant activity than the ligands alone.     

Synthesis, Characterization and the Antioxidative Activity of Zinc(II), Copper(II) and Nickel(II) Schiff-base Complexes

A naringenin Schiff-base ligand (H₃L) and its three complexes, MHL . nH₂O (M = Zn and Cu, n = 0.5) and NiH₂LOAc . 3.5H₂O, have been synthesized and characterized on the basis of elemental analysis, molar conductivity and i.r. spectrum, ¹H-n.m.r., u.v. spectra and thermal analyses. In addition, the suppression ratio for O₂^−˙ (a) and the suppression ratio for OH˙(b) were determined by the use of spectrophotometric methods. IC₅₀(a) and IC₅₀(b) of the complexes are given. The results show that compared to the ligand, the complexes exhibit high activity in the suppression of O₂^−˙ (a) and OH˙(b).     

Synthesis,Characterization and Anti-oxidative Activity of Cobalt(II), Nickel(II) and Iron(II) Schiff Base Complexes

Six complexes, M(HL)₂ · nH₂O (M=Co, Ni and Fe; n=4) with two ligands, 2-carboxy-benzaldehydebenzoylhydrazone (H₂L¹) and 2-carboxybenzaldehyde-(4′-methoxy)benzoylhydrazone (H₂L²), have been synthesized and characterized on the basis of elemental analyses, molar conductivities, i.r. spectra and thermal analyses. In addition, the suppression ratio for O₂^- (a) and the suppression ratio for OH^· (b) were determined with a 72 spectrophotometer. The 50% inhibition [IC₅₀ (a) and IC₅₀ (b)] of the complexes were studied. This study demonstrated that the complexes have activity in the suppression of O₂^- (a) and OH^· (b). In general, the antioxidative activities increased as the concentration of these complexes increased up to a selected extent. The complexes exhibit more effective antioxidants than the ligands and the series of the ligand (H₂L²) are better than the series of the ligand (H₂L¹) do.     

Organometallic Anticancer Compounds: Novel Half-Sandwich Ru(II)- and Co(II)-Arene Complexes,Their Cytotoxicity,and Apoptosis-Inducing Activity in Liver Cancer Cells

Russian Journal of General Chemistry - Organometallic complexes in many instances are characterised by potential anti-proliferative activity against different types of cancer cells. In particular,...     

Zn(II) Complexes with Quinoline Supported Amidate Ligands: Synthesis,Fluorescence, and Catalytic Activity

Zn(II) complexes of N-(quinolin-8-yl)picolinamide (HL¹) (1) and N²,N⁶-di(quinolin-8-yl)pyridine-2,6-dicarboxamide (H₂L²) (2) have been synthesized by deprotonation of the ligands and characterized by IR, NMR, and Single crystal X-ray crystallography. The mononuclear [Zn(L¹)₂] (3) and homodinuclear [Zn₂(L²)₂] (4) complexes are characterized by distorted octahedral geometries stabilized by hydrogen bonding and weak π···π interaction. The complexes demonstrate intense fluorescence bands in comparison with their corresponding ligands with well-distinguished intensity. The complexes act as efficient catalysts in various transesterification reactions. Among those, the best results have been achieved with complex 3 in conversion of 4-nitrophenylacetate into methyl acetate within 3 h.

     

Nickel(II) Complexes Derived from Bis-Schiff Bases: Synthesis,Crystal Structures,and Antimicrobial Activity

Russian Journal of Coordination Chemistry - Nickel(II) complexes derived from the bis-Schiff bases N,N'-bis(5-methylsalicylidene)-1,2-diaminocyclohexane (H2La),...